Gulf International Bank (Uk) LTD Biomarin Pharmaceutical Inc Transaction History

Gulf International Bank (Uk) LTD

  • $2.9 Billion
  • Q1 2025

A detailed history of Gulf International Bank (Uk) LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 11,414 shares of BMRN stock, worth $663,267. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,414
Previous 14,677 22.23%
Holding current value
$663,267
Previous $964,000 16.39%
% of portfolio
0.03%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$61.25 - $72.83 $199,858 - $237,644
-3,263 Reduced 22.23%
11,414 $806,000
Q4 2024

Feb 05, 2025
SELL
$61.93 - $70.49 $9,103 - $10,362
-147 Reduced 0.99%
14,677 $964,000
Q3 2024

Oct 30, 2024
SELL
$69.02 - $93.84 $55,008 - $74,790
-797 Reduced 5.1%
14,824 $1.04 Million
Q2 2024

Jul 10, 2024
SELL
$74.43 - $92.22 $45,923 - $56,899
-617 Reduced 3.8%
15,621 $1.29 Million
Q1 2024

Apr 11, 2024
BUY
$83.81 - $99.0 $8,800 - $10,395
105 Added 0.65%
16,238 $1.42 Million
Q4 2023

Jan 11, 2024
SELL
$76.22 - $98.51 $121,037 - $156,433
-1,588 Reduced 8.96%
16,133 $1.56 Million
Q3 2023

Oct 10, 2023
SELL
$85.07 - $94.48 $178,561 - $198,313
-2,099 Reduced 10.59%
17,721 $1.57 Million
Q2 2023

Aug 02, 2023
SELL
$86.68 - $100.3 $480,120 - $555,561
-5,539 Reduced 21.84%
19,820 $1.72 Million
Q1 2023

Apr 12, 2023
SELL
$87.74 - $117.27 $572,854 - $765,655
-6,529 Reduced 20.47%
25,359 $2.47 Million
Q4 2022

Feb 08, 2023
SELL
$80.93 - $108.63 $11,734 - $15,751
-145 Reduced 0.45%
31,888 $3.3 Million
Q1 2022

May 05, 2022
SELL
$74.28 - $92.69 $66,480 - $82,957
-895 Reduced 2.72%
32,033 $2.47 Million
Q4 2021

Jan 24, 2022
SELL
$71.72 - $91.47 $351,356 - $448,111
-4,899 Reduced 12.95%
32,928 $2.91 Million
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $280,685 - $340,631
-3,756 Reduced 9.03%
37,827 $2.86 Million
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $249,851 - $310,378
-3,441 Reduced 7.64%
41,583 $3.65 Million
Q3 2020

Oct 21, 2020
BUY
$71.87 - $131.03 $7,187 - $13,103
100 Added 0.22%
45,024 $3.43 Million
Q3 2019

Oct 08, 2019
SELL
$67.4 - $85.11 $29,386 - $37,107
-436 Reduced 0.96%
44,924 $3.03 Million
Q1 2019

Apr 18, 2019
BUY
$84.2 - $98.62 $50,520 - $59,172
600 Added 1.34%
45,360 $4.03 Million
Q4 2018

Jan 08, 2019
SELL
$80.14 - $106.07 $1 Million - $1.33 Million
-12,528 Reduced 21.87%
44,760 $3.81 Million
Q3 2018

Nov 05, 2018
BUY
$93.92 - $105.72 $213,668 - $240,513
2,275 Added 4.14%
57,288 $5.56 Million
Q1 2018

May 09, 2018
BUY
$77.67 - $92.63 $2,563 - $3,056
33 Added 0.06%
55,013 $4.46 Million
Q3 2017

Oct 11, 2017
BUY
$80.6 - $94.95 $4.43 Million - $5.22 Million
54,980
54,980 $5.12 Million

Others Institutions Holding BMRN

# of Institutions
668
Shares Held
184M
Call Options Held
1.24M
Put Options Held
957K
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Gulf International Bank (Uk) LTD Portfolio

Follow Gulf International Bank (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email